Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management

Immunotherapy that includes programmed cell death-1 (PD-1), programmed cell death- ligand 1 (PD-L1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibitors has revolutionized the therapeutic strategy in multiple malignancies. Although it has achieved significant breakthrough in advanced non-small c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qin, Tang, Liansha, Zhou, Yuwen, He, Wenbo, Li, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195248/
https://www.ncbi.nlm.nih.gov/pubmed/34122422
http://dx.doi.org/10.3389/fimmu.2021.663986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195248/
https://www.ncbi.nlm.nih.gov/pubmed/34122422
http://dx.doi.org/10.3389/fimmu.2021.663986

Ejemplares similares